To dismiss claims of poor-quality pharma drugs as an effort by Big Pharma to hurt India’s growing reputation as pharmacy to the world — a non-tariff barrier of sorts — isn’t as extreme a conspiracy theory as some may believe. Yet, to pretend all is well with the drug licensing and regulatory regime would be […]